Patient 32 carried V659E TMD mutation and was also detected to carry the extracellular EGFR missense mutation A289V which has been previously reported as an oncogenic mutation in glioblastoma (Dai et al., 2018; Thorne et al., 2017). The gene discussed is EGFR; the disease is glioblastoma.